Company Filing History:
Years Active: 1993
Title: Melvin Silberklang: Innovator in Anticoagulant Protein Development
Introduction
Melvin Silberklang is a notable inventor based in Englewood, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of anticoagulant proteins. His work has implications for medical treatments related to blood coagulation.
Latest Patents
Silberklang holds a patent for an antistasin derived anticoagulant protein. This protein has a molecular weight of about 6,000 daltons and is biologically active in the inhibition of Factor Xa during the blood coagulation cascade. The patent also includes a method for producing the protein, methods for inhibiting blood coagulation using the protein, and suitable pharmaceutical compositions.
Career Highlights
Melvin Silberklang is associated with Merck & Co., Inc., a leading pharmaceutical company. His work at Merck has allowed him to focus on innovative solutions in the field of anticoagulation therapy. His research has the potential to improve patient outcomes in various medical conditions related to blood clotting.
Collaborations
Silberklang has collaborated with esteemed colleagues, including Linda O Palladino and Jwu-Sheng Tung. These collaborations have fostered a productive research environment, leading to advancements in the understanding and application of anticoagulant proteins.
Conclusion
Melvin Silberklang's contributions to the field of anticoagulant proteins highlight his innovative spirit and dedication to medical research. His patent and work at Merck & Co., Inc. demonstrate the impact of his inventions on healthcare.